Specifications

Anti-cancer properties have been attributed to CLA.It has been reported that CLA can up-regulate the tumor suppressor gene PTPRG

Conjugated Linoleic Acid FFA 40% Powder

Anti-cancer properties have been attributed to CLA, and studies on mice and rats show encouraging results in hindering the growth of tumors in mammary, skin, and colon tissues. It has been reported that CLA can up-regulate the tumor suppressor gene PTPRG, and may have anti-cancer properties.

 

Conjugated Linoleic Acid FFA 40% Powder

BOTANICAL NAME:	Carthamus tinctorius
PART OF PLANT USED:	Seed
ORIGIN OF RAW MATERIAL:	China
COUNTRY OF PROCESSING:	China
ISSUE DATE:	Apr. 8th, 2009
PRODUCT NO.:	XQD-CLA-FFAP40
PHYSICAL/CHEMICAL	SPECIFICATIONS
APPEARANCE	A white or off white powder
PURE CONJUGATED LINOLEIC ACID,%	≥40.0
FATTY ACID COMPOSITION
CONJUGATED LINOLEIC ACID,%	≥78.0
ACTIVE C9T11 CLA (%)	≥37.0
ACTIVE T10C12 CLA (%)	≥37.0
FAT CONTENT,%	≥50
MOISTURE,%	≤5.0
BULK DENSITY, g/ml	≥0.35.
PARTICLES (MESH)	100% through 60 mesh
HEAVY METALS,PPM	5.0
LEAD,PPM	≤1.0
ARSENIC,PPM	≤1.0
CADMIUM,PPM	≤1.0
MERCURY,PPM	≤0.1
MICROBIOLOGY
TOTAL PLATE COUNT,CFU/G	≤1,000
YEASTS AND MOLDS,CFU/G	≤100
E. Coli	Negative/g
Salmonella	Negative/25g
Staphyloccous aureus	Negative/25g

PACKAGING: Available 10.0kg/bag,20.0kg/carton in vacuum

STORAGE AND HANDING: CLA FFA Powder should be stored in a dry and not in direct sunlight. The preferred storing temperature is 10-25 ^oC

SHELF LIFE: It is recommended to use the entire content after opening. In its original packaging, the product is

stable for at least two years.